December 22, 2021 05:23 pm
Original Link: https://www.theverge.com/2021/12/22/22810371/pfizer-merck-paxlovid-covid-antiviral-fda-authorization-omicron
FDA authorizes first COVID-19 antiviral pill
On Wednesday, the Food and Drug Administration authorized the first antiviral pill to treat COVID-19, a move that gives doctors another tool to fight the disease. The treatment, made by Pfizer, curbs the risk of hospitalization and death in high-risk patients infected with the coronavirus.
Called Paxlovid, the treatment includes 30 pills taken at home over five days. It has to be started within a few days of symptoms — which could be a challenge in the United States, where it may be difficult for many people to get a COVID-19 test, a result, and see a doctor for a prescription in that window.
Paxlovid cut the risk of hospitalization and death by 89 percent for adults with COVID-19 at high risk of developing severe disease when it was...
Original Link: https://www.theverge.com/2021/12/22/22810371/pfizer-merck-paxlovid-covid-antiviral-fda-authorization-omicron
Share this article:
Tweet
View Full Article
The Verge
The Verge is an ambitious multimedia effort founded in 2011More About this Source Visit The Verge